<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="static/style.xsl"?><OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2026-06-29T07:30:13Z</responseDate><request verb="GetRecord" identifier="oai:docta.ucm.es:20.500.14352/93718" metadataPrefix="oai_dc">https://docta.ucm.es/rest/oai/request</request><GetRecord><record><header><identifier>oai:docta.ucm.es:20.500.14352/93718</identifier><datestamp>2025-03-18T14:08:17Z</datestamp><setSpec>com_20.500.14352_14</setSpec><setSpec>col_20.500.14352_15</setSpec></header><metadata><oai_dc:dc xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:doc="http://www.lyncode.com/xoai" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
   <dc:title>Implication of miR-155-5p and miR-143-3p in the Vascular Insulin Resistance and Instability of Human and Experimental Atherosclerotic Plaque</dc:title>
   <dc:creator>González-López, Paula</dc:creator>
   <dc:creator>Ares-Carral, Carla</dc:creator>
   <dc:creator>López-Pastor, Andrea R.</dc:creator>
   <dc:creator>Infante-Menéndez, Jorge</dc:creator>
   <dc:creator>González Illanes, Tamara</dc:creator>
   <dc:creator>Vega de Ceniga, Melina</dc:creator>
   <dc:creator>Esparza, Leticia</dc:creator>
   <dc:creator>Beneit, Nuria</dc:creator>
   <dc:creator>Martín-Ventura, José Luis</dc:creator>
   <dc:creator>Escribano Illanes, Óscar</dc:creator>
   <dc:creator>Gómez Hernández, María De La Almudena</dc:creator>
   <dc:subject>577.2</dc:subject>
   <dc:subject>atherosclerosis</dc:subject>
   <dc:subject>miR-155-5p</dc:subject>
   <dc:subject>miR-143-3p</dc:subject>
   <dc:subject>unstable plaque</dc:subject>
   <dc:subject>apoptosis</dc:subject>
   <dc:subject>AKT</dc:subject>
   <dc:subject>IGF-IIR</dc:subject>
   <dc:subject>Biología molecular (Farmacia)</dc:subject>
   <dc:subject>Bioquímica (Farmacia)</dc:subject>
   <dc:subject>2302 Bioquímica</dc:subject>
   <dc:subject>2415 Biología Molecular</dc:subject>
   <dc:description>(1) Background: Cardiovascular diseases (CVDs) are the main cause of death in developed countries, being atherosclerosis, a recurring process underlying their apparition. MicroRNAs (miRNAs) modulate the expression of their targets and have emerged as key players in CVDs; (2) Methods: 18 miRNAs were selected (Pubmed and GEO database) for their possible role in promoting atherosclerosis and were analysed by RT-qPCR in the aorta from apolipoprotein E-deficient (ApoE−/−) mice. Afterwards, the altered miRNAs in the aorta from 18 weeks-ApoE−/− mice were studied in human aortic and carotid samples; (3) Results: miR-155-5p was overexpressed and miR-143-3p was downregulated in mouse and human atherosclerotic lesions. In addition, a significant decrease in protein kinase B (AKT), target of miR-155-5p, and an increase in insulin-like growth factor type II receptor (IGF-IIR), target of miR-143-3p, were noted in aortic roots from ApoE−/− mice and in carotid plaques from patients with advanced carotid atherosclerosis (ACA). Finally, the overexpression of miR-155-5p reduced AKT levels and its phosphorylation in vascular smooth muscle cells, while miR-143-3p overexpression decreased IGF-IIR reducing apoptosis in vascular cells; (4) Conclusions: Our results suggest that miR-155-5p and miR-143-3p may be implicated in insulin resistance and plaque instability by the modulation of their targets AKT and IGF-IIR, contributing to the progression of atherosclerosis.</dc:description>
   <dc:description>Ministerio de Ciencia e Innovación y Universidades (España)</dc:description>
   <dc:description>Banco Santander</dc:description>
   <dc:description>Universidad Complutense de Madrid</dc:description>
   <dc:description>Depto. de Bioquímica y Biología Molecular</dc:description>
   <dc:description>Fac. de Farmacia</dc:description>
   <dc:description>TRUE</dc:description>
   <dc:description>pub</dc:description>
   <dc:date>2024-01-17T19:21:42Z</dc:date>
   <dc:date>2024-01-17T19:21:42Z</dc:date>
   <dc:date>2022-09-06</dc:date>
   <dc:type>journal article</dc:type>
   <dc:type>VoR</dc:type>
   <dc:identifier>https://hdl.handle.net/20.500.14352/93718</dc:identifier>
   <dc:identifier>1661-6596</dc:identifier>
   <dc:identifier>10.3390/ijms231810253</dc:identifier>
   <dc:identifier>1422-0067</dc:identifier>
   <dc:language>eng</dc:language>
   <dc:relation>info:eu-repo/grantAgreement/RTI-2018-095098-B100</dc:relation>
   <dc:relation>info:eu-repo/grantAgreement/PID2021-123076OB-I00</dc:relation>
   <dc:relation>info:eu-repo/grantAgreement/PR75/18-21572</dc:relation>
   <dc:relation>info:eu-repo/grantAgreement/AENC1/22-29754</dc:relation>
   <dc:relation>González-López P, Ares-Carral C, López-Pastor AR, Infante-Menéndez J, González Illaness T, Vega De Ceniga M, et al. Implication of miR-155-5p and miR-143-3p in the Vascular Insulin Resistance and Instability of Human and Experimental Atherosclerotic Plaque. IJMS 2022;23:10253. https://doi.org/10.3390/ijms231810253.</dc:relation>
   <dc:rights>Attribution 4.0 International</dc:rights>
   <dc:rights>http://creativecommons.org/licenses/by/4.0/</dc:rights>
   <dc:rights>open access</dc:rights>
   <dc:format>application/pdf</dc:format>
   <dc:publisher>MDPI</dc:publisher>
</oai_dc:dc></metadata></record></GetRecord></OAI-PMH>